"A model is just a model. It's not enough. A pipeline has to be made so companies can actually use the model in their own R&D process."
"These are powerful and versatile models, but they require a lot of work to hammer into a shape that people can actually use day to day."
"Converge Bio offers a series of improvements that can be done securely and using a company's own IP, beginning with data enrichment."
"The market is very fragmented, but pharma and biotech want to consume this technology in a consolidated way, in one place."
Collection
[
|
...
]